Cargando…

Interleukin-8 in Colorectal Cancer: A Systematic Review and Meta-Analysis of Its Potential Role as a Prognostic Biomarker

Among soluble actors that have emerged as druggable factors, the chemokine interleukin-8 (IL-8) has emerged as a possible determinant of response to immunotherapy and targeted treatment in several cancer types; however, its prognostic/predictive role in colorectal cancer (CRC) remains to be establis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazzichetto, Chiara, Milella, Michele, Zampiva, Ilaria, Simionato, Francesca, Amoreo, Carla Azzurra, Buglioni, Simonetta, Pacelli, Chiara, Le Pera, Loredana, Colombo, Teresa, Bria, Emilio, Zeuli, Massimo, Del Bufalo, Donatella, Sperduti, Isabella, Conciatori, Fabiana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599846/ https://www.ncbi.nlm.nih.gov/pubmed/36289899 http://dx.doi.org/10.3390/biomedicines10102631

Ejemplares similares

BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer
por: Conciatori, Fabiana, et al.
Publicado: (2020)

Fibroblast-Induced Paradoxical PI3K Pathway Activation in PTEN-Competent Colorectal Cancer: Implications for Therapeutic PI3K/mTOR Inhibition
por: Conciatori, Fabiana, et al.
Publicado: (2022)

mTOR Cross-Talk in Cancer and Potential for Combination Therapy
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Role of mTOR Signaling in Tumor Microenvironment: An Overview
por: Conciatori, Fabiana, et al.
Publicado: (2018)

Colorectal cancer stem cells properties and features: evidence of interleukin-8 involvement
por: Conciatori, Fabiana, et al.
Publicado: (2019)

AXL Receptor in Breast Cancer: Molecular Involvement and Therapeutic Limitations
por: Falcone, Italia, et al.
Publicado: (2020)

Advances in Tumor-Stroma Interactions: Emerging Role of Cytokine Network in Colorectal and Pancreatic Cancer
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

Editorial: Tailoring immunotherapy in gastrointestinal cancer: the role of circulating factors
por: Ugel, Stefano, et al.
Publicado: (2023)

RNA-Based Strategies for Cancer Therapy: In Silico Design and Evaluation of ASOs for Targeted Exon Skipping
por: Pacelli, Chiara, et al.
Publicado: (2023)

Tumor Microenvironment: Implications in Melanoma Resistance to Targeted Therapy and Immunotherapy
por: Falcone, Italia, et al.
Publicado: (2020)

PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise?
por: Bazzichetto, Chiara, et al.
Publicado: (2019)

From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

PTEN Function at the Interface between Cancer and Tumor Microenvironment: Implications for Response to Immunotherapy
por: Conciatori, Fabiana, et al.
Publicado: (2020)

Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
por: Del Curatolo, Anais, et al.
Publicado: (2018)

Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
por: Bazzichetto, Chiara, et al.
Publicado: (2020)

The Key Roles of PTEN in T-Cell Acute Lymphoblastic Leukemia Development, Progression, and Therapeutic Response
por: Martelli, Alberto M., et al.
Publicado: (2019)

PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer
por: Milella, Michele, et al.
Publicado: (2017)

SEMA6A/RhoA/YAP axis mediates tumor-stroma interactions and prevents response to dual BRAF/MEK inhibition in BRAF-mutant melanoma
por: Loria, Rossella, et al.
Publicado: (2022)

TRF2 and VEGF-A: an unknown relationship with prognostic impact on survival of colorectal cancer patients
por: Dinami, Roberto, et al.
Publicado: (2020)

Cross-sectional analysis of circulating tumor DNA in primary colorectal cancer at surgery and during post-surgery follow-up by liquid biopsy
por: Allegretti, Matteo, et al.
Publicado: (2020)

Bcl-2 family inhibitors sensitize human cancer models to therapy
por: Valentini, Elisabetta, et al.
Publicado: (2023)

Dual targeting of HER3 and MEK may overcome HER3-dependent drug-resistance of colon cancers
por: Bon, Giulia, et al.
Publicado: (2016)

Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
por: Loupakis, Fotios, et al.
Publicado: (2010)

JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer
por: Giordano, Guido, et al.
Publicado: (2019)

HMGA1/E2F1 axis and NFkB pathways regulate LPS progression and trabectedin resistance
por: Loria, Rossella, et al.
Publicado: (2018)

Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of Ki67 assay according to histology: prognostic relevance for resected early stage ‘pure’ and ‘mixed’ lobular breast cancer
por: Carbognin, Luisa, et al.
Publicado: (2016)

Histone acetyltransferase inhibitor CPTH6 preferentially targets lung cancer stem-like cells
por: Di Martile, Marta, et al.
Publicado: (2016)

BCL-X(L) overexpression promotes tumor progression-associated properties
por: Trisciuoglio, Daniela, et al.
Publicado: (2017)

Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response
por: Valenti, Fabio, et al.
Publicado: (2021)

Evaluation of nutritional status in non-small-cell lung cancer: screening, assessment and correlation with treatment outcome
por: Trestini, Ilaria, et al.
Publicado: (2020)

Histone deacetylase inhibitor ITF2357 leads to apoptosis and enhances doxorubicin cytotoxicity in preclinical models of human sarcoma
por: Di Martile, Marta, et al.
Publicado: (2018)

A divergent role for estrogen receptor-beta in node-positive and node-negative breast cancer classified according to molecular subtypes: an observational prospective study
por: Novelli, Flavia, et al.
Publicado: (2008)

Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells
por: Di Martile, Marta, et al.
Publicado: (2020)

MKK3 sustains cell proliferation and survival through p38DELTA MAPK activation in colorectal cancer
por: Stramucci, Lorenzo, et al.
Publicado: (2019)

Pancreatic Enzyme Replacement Therapy in Patients Undergoing First-Line Gemcitabine Plus nab-paclitaxel for Advanced Pancreatic Adenocarcinoma
por: Trestini, Ilaria, et al.
Publicado: (2021)

Exploring association of melanoma-specific Bcl-xL with tumor immune microenvironment
por: Lucianò, Anna Maria, et al.
Publicado: (2023)

Role of gonadotropin-releasing hormone analogues in metastatic male breast cancer: results from a pooled analysis
por: Di Lauro, Luigi, et al.
Publicado: (2015)

Prognostic Value of Beta-Tubulin-3 and c-Myc in Muscle Invasive Urothelial Carcinoma of the Bladder
por: Massari, Francesco, et al.
Publicado: (2015)

Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
por: Carbognin, Luisa, et al.
Publicado: (2015)

Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials
por: Cuppone, Federica, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jpvvpe5jhl17mncvomhg2a9qca